USA flag logo/image

An Official Website of the United States Government

Isozyme Identification of Metabolic Pathways of Herbals

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
53740
Program Year/Program:
2001 / SBIR
Agency Tracking Number:
1R43AT000792-01
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
BIOANALYTICAL SYSTEMS, INC. (BASI)
BIOANALYTICAL SYSTEMS, INC. (BASI) 2701 KENT AVE WEST LAFAYETTE, IN 47906 1389
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2001
Title: Isozyme Identification of Metabolic Pathways of Herbals
Agency: HHS
Contract: N/A
Award Amount: $91,514.00
 

Abstract:

DESCRIPTION (provided by applicant): This proposal will develop analytical methodology to identify key metabolic pathways and the metabolizing enzymes of botanicals responsible for drug interactions. Initially we will focus on the main active ingredients of widely used botanicals, green tea (epigallocatechin gallate), St. John's wort (hypericin and hyperforin), and milk thistle weed (silybin). Metabolism of these compounds will be investigated in vitro in liver microsomes and expressed human enzymes. Liquid chromatography coupled with tandem mass spectrometry will be used to identify the phase I metabolites. The cytochrome P450 isoforms will be identified using chemical inhibitor probes and specific expressed enzymes. Enzyme kinetic and inhibition parameters of these compounds will be evaluated to predict the interactions with known drugs. A web-accessible, interactive relational database will be developed to include the findings such as specific isoforms, metabolites formed, metabolic reactions and enzyme kinetics and the inhibition constants of the above standards. The database will be expanded in Phase II to also include in vivo data of botanical extracts and their synergistic effects to provide information to pharmacists and physicians. PROPOSED COMMERCIAL APPLICATION: The procedures and automated methods developed in these studies will be used to provide contract research services to pharmaceutical/botanical industry. The research will result is a database that could be sold to healthcare professionals and pharmaceutical industry.

Principal Investigator:

P. C. Gunaratna

Business Contact:


7654632127
MICHELLE@BIOANALYTICAL.COM
Small Business Information at Submission:

BIOANALYTICAL SYSTEMS, INC.
2701 KENT AVE WEST LAFAYETTE, IN 47906

EIN/Tax ID: 351345024
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No